Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-19

Clinical Trial Update: Washed Microbiota Transplantation for Tourette's Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating washed microbiota transplantation for Tourette syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Second Hospital of Nanjing Medical University | Conditions: Tourette Syndrome | Phase 1 | Status: RECRUITING